Riskpilot← Back to searchSign inGet full accessRoslagstandläkarna AB
ABActiveOrg 5566988373Hantverkaregatan 24Dental practice care activities · NACE 8623Est. 200610 employees
Revenue 2024
SEK 14,3M
-5% vs 2023
EBITDA margin
20.7%
-19% vs 2023
Equity ratio
74.6%
Financial strength
Net profit 2024
SEK 2,1M
-13% vs 2023
| Revenue | SEK 14,3M | -5% |
| EBITDA | SEK 3M | -19% |
| Net profit | SEK 2,1M | -13% |
| Total assets | SEK 18,3M | -8% |
| Equity | SEK 13,7M | -12% |
| Employees | 10 | — |
Legal name
Roslagstandläkarna AB
Org number
5566988373
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
28 februari 2006
Share capital
SEK 120 000
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets verksamhet är tandvård och därmed förenlig verksamhet.
Address
Hantverkaregatan 24
Phone
+46176225770
Email
bengt.walter.26@ptj.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 193 | 11 840 | 14 393 | 15 057 | 14 279 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 041 | 2 742 | 3 253 | 3 656 | 2 950 |
| Depreciation & amort. | −13 | −13 | −375 | −373 | −435 |
| EBIT | 3 028 | 2 729 | 2 878 | 3 283 | 2 515 |
| Net financials | −87 | −100 | −99 | 9 | 38 |
| Profit before tax | 2 687 | 2 374 | 2 311 | 2 996 | 2 613 |
| Tax | −584 | −519 | −494 | −626 | −546 |
| Net profit | 2 103 | 1 855 | 1 817 | 2 370 | 2 067 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 401 | 16 878 | 18 701 | 19 801 | 18 309 |
| Equity | 9 543 | 11 399 | 13 216 | 15 587 | 13 654 |
| Long-term debt | 4 669 | 4 345 | 4 473 | 3 123 | 2 899 |
| Short-term debt | 2 183 | 1 129 | 834 | 895 | 1 621 |
| Total debt | 6 852 | 5 474 | 5 307 | 4 018 | 4 520 |
EBITDA margin
20.7%
This company
15.8%
Market median
+31% vs market
20202024
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20202024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
14.5%
This company
8.1%
Market median
+79% vs market
20202024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LK Audit | Audit | 2025 |
| Former (3) | ||
KE | Audit | 2021 – 2022 |
LP Audit | Audit | 2022 – 2025 |
AC Auditor Substitute | Auditor Substitute | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hardwave Investment AB
Roslagstandläkarna AB Board members of Roslagstandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Kenneth Elton | Audit | 0 companies |
| Karin Elisabeth Hammarberg | Audit | 0 companies |
| Lars Peter Borwin | Audit | 0 companies |
| Alexandra Camilla L Lindqvist | Auditor Substitute | 0 companies |
| Ali Pahlawan Ialy | Deputy Board Member | 0 companies |
| Hamid Reza Haghighi | Board of Directors | 0 companies |